- Home
- BLZE vs ARTV Comparison
BLZE vs ARTV Comparison
Compare BLZE & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLZE
- ARTV
- Stock Information
- Founded
- BLZE 2007
- ARTV 2019
- Country
- BLZE United States
- ARTV United States
- Employees
- BLZE N/A
- ARTV N/A
- Industry
- BLZE Computer Software: Prepackaged Software
- ARTV
- Sector
- BLZE Technology
- ARTV
- Exchange
- BLZE Nasdaq
- ARTV NYSE
- Market Cap
- BLZE 280.2M
- ARTV 275.7M
- IPO Year
- BLZE 2021
- ARTV 2024
- Fundamental
- Price
- BLZE $6.88
- ARTV $10.86
- Analyst Decision
- BLZE Strong Buy
- ARTV Strong Buy
- Analyst Count
- BLZE 4
- ARTV 5
- Target Price
- BLZE $11.50
- ARTV $21.25
- AVG Volume (30 Days)
- BLZE 648.0K
- ARTV 45.7K
- Earning Date
- BLZE 02-13-2025
- ARTV 11-12-2024
- Dividend Yield
- BLZE N/A
- ARTV N/A
- EPS Growth
- BLZE N/A
- ARTV N/A
- EPS
- BLZE N/A
- ARTV N/A
- Revenue
- BLZE $122,579,000.00
- ARTV $2,601,000.00
- Revenue This Year
- BLZE $27.53
- ARTV N/A
- Revenue Next Year
- BLZE $14.73
- ARTV N/A
- P/E Ratio
- BLZE N/A
- ARTV N/A
- Revenue Growth
- BLZE 27.41
- ARTV N/A
- 52 Week Low
- BLZE $4.91
- ARTV $9.68
- 52 Week High
- BLZE $12.65
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- BLZE 50.61
- ARTV N/A
- Support Level
- BLZE $6.70
- ARTV N/A
- Resistance Level
- BLZE $7.16
- ARTV N/A
- Average True Range (ATR)
- BLZE 0.28
- ARTV 0.00
- MACD
- BLZE 0.03
- ARTV 0.00
- Stochastic Oscillator
- BLZE 55.88
- ARTV 0.00
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and other regions.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.